Literature DB >> 35538228

The interfacial interactions of nanomaterials with human serum albumin.

Min He1,2, Wenxiang Zhang1,3, Zheyi Liu1, Lingqiang Zhou1, Xiaoming Cai4, Ruibin Li4, Yuanjiang Pan3, Fangjun Wang5,6.   

Abstract

The fates of nanomaterials (NMs) in vivo are greatly dependent on their interactions with human serum proteins. However, the interfacial molecular details of NMs-serum proteins are still difficult to be probed. Herein, the molecular interaction details of human serum albumin (HSA) with Au and SiO2 nanoparticles have been systematically interrogated and compared by using lysine reactivity profiling mass spectrometry (LRP-MS). We demonstrated the biocompatibility of Au is better than SiO2 nanoparticles and the NMs surface charge state played a more important role than particle size in the combination of NMs-HSA at least in the range of 15-40 nm. Our results will contribute to the fundamental mechanism understanding of NMs-serum protein interactions as well as the NMs rational design.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Human serum proteins; Interfacial molecular details; Lysine reactivity profiling; Mass spectrometry; Nanomaterials

Year:  2022        PMID: 35538228     DOI: 10.1007/s00216-022-04089-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  32 in total

1.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

2.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

3.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

Review 4.  Understanding biophysicochemical interactions at the nano-bio interface.

Authors:  Andre E Nel; Lutz Mädler; Darrell Velegol; Tian Xia; Eric M V Hoek; Ponisseril Somasundaran; Fred Klaessig; Vince Castranova; Mike Thompson
Journal:  Nat Mater       Date:  2009-06-14       Impact factor: 43.841

Review 5.  Immunological basis for enhanced immunity of nanoparticle vaccines.

Authors:  Hannah G Kelly; Stephen J Kent; Adam K Wheatley
Journal:  Expert Rev Vaccines       Date:  2019-02-14       Impact factor: 5.217

Review 6.  Nanotechnology-based photoimmunological therapies for cancer.

Authors:  Yong Li; Xiaosong Li; Feifan Zhou; Austin Doughty; Ashley R Hoover; Robert E Nordquist; Wei R Chen
Journal:  Cancer Lett       Date:  2018-11-24       Impact factor: 8.679

Review 7.  Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.

Authors:  Mauro Sousa de Almeida; Eva Susnik; Barbara Drasler; Patricia Taladriz-Blanco; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Chem Soc Rev       Date:  2021-03-05       Impact factor: 54.564

8.  Biomimetic Hybrid Membrane-Coated Xuetongsu Assisted with Laser Irradiation for Efficient Rheumatoid Arthritis Therapy.

Authors:  Huanghe Yu; Jialong Fan; Nuzhat Shehla; Yixing Qiu; Ye Lin; Zhou Wang; Liang Cao; Bin Li; Muhammad Daniyal; Yan Qin; Caiyun Peng; Xiong Cai; Bin Liu; Wei Wang
Journal:  ACS Nano       Date:  2021-12-29       Impact factor: 15.881

9.  Thermal and photoinduced reduction of ionic Au(III) to elemental Au nanoparticles by dissolved organic matter in water: possible source of naturally occurring Au nanoparticles.

Authors:  Yongguang Yin; Sujuan Yu; Jingfu Liu; Guibin Jiang
Journal:  Environ Sci Technol       Date:  2014-02-11       Impact factor: 9.028

10.  Nano-drug System Based on Hierarchical Drug Release for Deep Localized/Systematic Cascade Tumor Therapy Stimulating Antitumor Immune Responses.

Authors:  Yuchu He; Cong Cong; Xiaoling Li; Ruiyan Zhu; Anshuo Li; Shuxian Zhao; Xiaowei Li; Xin Cheng; Mengxue Yang; Dawei Gao
Journal:  Theranostics       Date:  2019-05-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.